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N The nanoscale design of nanocrystals by the controlled incorpo-
ration of dopant impurities is a research fi eld of fundamental 
interest with great potential for numerous disruptive technolo-
gies. [ 1–3 ] In particular, 3 d transition metal ions (Mn, Co, etc.) with 
their  d -shell electronic confi gurations can imprint a nanocrystal 
with magnetic properties of relevance for innovative applications 
ranging from bio-imaging [ 4,5 ] to spintronics. [ 1,5 ] For example, col-
loidal nanocrystals doped with transition metals could provide 
versatile contrast agents for multimodal medical imaging, i.e., 
for contrast-enhanced magnetic resonance imaging (MRI) and 
confocal microscopy. [ 4 ] To date, a variety of nanoparticles (e.g., 
Fe 3 O 4 , FePt, MnFe 2 O 4 , and MnO) have been used for enhanced-
contrast MRI, [ 5,6 ] but these require functionalization with fl uo-
rescent organic dyes for optical imaging and their solubility in 
physiological solvents demands modifi cation of the nanocrystal 
surface. Luminescent, paramagnetic colloidal quantum dots, 
QDs (e.g., Mn-doped Si, ZnS, CdS/ZnS QDs) have also been 
previously studied. [ 7–9 ] However, these nanostructures require 
phase transfer to address water solubility and/or the visible pho-
toluminescence (PL) emission limits their application in in vivo 
imaging due to strong photon absorption by biological tissues. 
Thus despite extensive research in this fi eld, paramagnetic nano-
particles with fl uorescence in the near-infrared (NIR) spectral 
region of the biological optical window are still not available. 
 In this work, we report paramagnetic, NIR fl uorescent Mn-
doped PbS colloidal nanocrystals in an aqueous solution. We 
demonstrate the successful incorporation of Mn atoms in the © 2013 The Authors. Published by
 DOI:  10.1002/ppsc.201300184 
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Part. Part. Syst. Charact. 2013, 30, 945–949nanocrystals, which contain up to 8% Mn. The nanocrystals 
are optically active at room temperature in the technologically 
important biological window between 1.2  μ m and 0.8  μ m; also, 
the Mn atoms imprint the nanoparticles with paramagnetic 
properties. Preliminary cytoxicity studies show that the expo-
sure of human cell lines to the nanoparticles at concentrations 
up to 0.2 mg mL −1 does not induce any adverse effect, thus pro-
viding guidelines on safe doses for further toxicology studies 
and future applications in medical imaging. 
 Our Mn-doped PbS nanocrystals in an aqueous solution 
differ from previously reported nanostructures based on PbS 
nanowires [ 10,11 ] and PbS nanocrystals in glass matrices [ 12,13 ] or 
in organic solvents. [ 14 ] To synthesize the Mn-doped PbS nano-
particles, we prepared a Pb 2+ precursor solution containing 
2.5 × 10 −4 mol of lead acetate Pb(CH 3 COO) 2 , 1.5 × 10 −3 mol 
of thioglycerol (TGL) and 5 × 10 −4 mol of dithioglycerol (DTG) 
in 15 mL of deionized water, where the thiols act as capping 
agents. [ 15,16 ] The pH of the solution was adjusted to a value of 
11.0 by addition of triethylamine. While maintaining the pH of 
the solution, manganese acetate Mn(CH 3 COO) 2 salt was added 
with Mn concentration,  x , up to 18%. To facilitate the incor-
poration of the Mn atoms during the nucleation stage of the 
nanocrystal growth, a 0.1  M solution of sodium sulfi de Na 2 S was 
added slowly to the reaction mixture at a molar ratio MR = 1:0.3 
of Pb(Mn) to S. The synthesis was performed under N 2 fl ux 
with a concentration of nanoparticles of up to 10 mg mL −1 . The 
solutions were stored in a refrigerator at  T = 4 °C under N 2 
atmosphere and were found to be stable for at least 6 months. 
The solutions of the nanoparticles in bovine serum media used 
for the in vitro toxicity studies were also stable. 
 Figure  1 a shows typical high-resolution transmission elec-
tron microscopy (HRTEM) images for Mn-doped PbS nano-
particles with average diameter  d approximately equal to 5 nm. 
HRTEM, transmission electron microscopy (TEM), and selected 
area electron diffraction studies indicate that the nanocrys-
tals retain the rock-salt crystal structure of bulk PbS and that 
the size distribution of the nanoparticles does not change fol-
lowing the incorporation of Mn. Size distribution profi les were 
obtained from analysis of the atomic force microscopy (AFM) 
images. The AFM study shows that the average nanoparticle 
diameter is  d = (4.5 ± 1.8) nm for samples with  x = 0%, 5% and 
10% (see Supporting Information). The incorporation of Mn in 
the nanocrystals was assessed by energy-dispersive X-ray (EDX) 
spectroscopy. The EDX spectra show the characteristic EDX 
peak associated with Mn at an energy of 5.9 keV (see Figure  1 b). 
The Mn concentration, Mn EDX , estimated from the analysis of 
the EDX data is smaller than  x , i.e., only a fraction of Mn used 














 Figure 1.  a) HRTEM images and b) typical EDX spectrum of Mn-doped PbS nanoparticles. 
c) Comparison between the Mn content measured by EDX, Mn EDX , (symbols) and the nominal 
Mn content (continuous line) at various  x . The dashed line is a guide to the eye. The right axis 
represents the number of Mn ions per QD. For example, Mn EDX = 4% for  x = 10%, which corresponds to 
an average number of Mn ions per QD,  n Mn = 110 (Figure  1 c). 
As can be seen in Figure  1 c, the deviation of Mn  from  x EDX
 Figure 2.  a) Room temperature ( T = 295 K) K-band EPR spectra for Mn-doped PbS nanocrystals 
with  x from 0.5 to 5%. Curves are displaced along the vertical axis for clarity. b) Magnetization 
as a function of magnetic fi eld,  B , at different temperatures,  T , for  x = 10%. increases for increasing Mn concentrations. 
 It is well established that there are funda-
mental limits to the doping concentrations 
that can be achieved in crystalline solids. Fur-
thermore, the incorporation of dopant atoms 
into a single nanocrystal is governed by more 
complex mechanisms than in the bulk due 
to the large surface to volume ratio of the 
nanocrystals and a tendency of the dopants 
to migrate to the surface by a self-purifi cation 
process. [ 17 ] Assessing the exact position of 
the dopants within a nanocrystal, i.e., core 
or surface, and their preferential site within 
the crystal lattice, is a challenging task that 
requires the development of sensitive micro-
scopic techniques. This assessment is further 
complicated by the statistical distribution of 
the dopant concentration within an ensemble 
of nanoparticles. In this work, we focus on the 
magnetic and optical properties of ensembles 
of Mn-doped PbS nanoparticles, as probed by 
electron paramagnetic resonance (EPR) and 
PL for a wide range of Mn concentrations. 
 Figure  2 a shows the room temperature 
K-band EPR spectra of Mn-doped PbS nano-
particles. For  x = 0.5%, the EPR spectrum wileyonlinelibrary.com © 2013 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, shows six narrow resonances superimposed 
on a broad background signal. These six lines 
are due to magnetic resonance transitions 
between states that are split by the hyper-
fi ne interaction between  d -shell electrons 
( S = 5/2) and the nuclear spins ( I = 5/2) of 
the Mn 2+ ions. The asymmetric shape of the 
EPR lines indicates an additional unresolved 
hyperfi ne splitting due to the contribution 
from Mn ions on the surface and in the core 
of the nanoparticles. With increasing Mn 
content, the six resonances become broader 
until they merge into a single broad line-
shape for  x = 5% (see Figure  2 a) and  x = 10% 
(not shown) due to an increasing strength 
of Mn–Mn dipolar interactions. The simula-
tion of the broad EPR spectra using a single 
Lorentzian lineshape indicates an hyperfi ne 
splitting constant  A = 9.25 mT and a  g -factor 
value of ≈2, similar to those reported before 
for Mn-doped PbS nanoparticles in glass 
matrix. [ 12 ] SQUID measurements confi rm 
that the nanoparticles are paramagnetic: for 
 x = 10%, the magnetization tends to satu-
rate for  B > 3T to a value of 6 emu g −1 at  T = 
1.8 K that decreases with increasing  T (see 
Figure  2 b). This value is much larger than 
that reported for nanoparticles in organic 
solution (0.5 emu g −1 for  x = 3%). [ 14 ] 
 Unlike Mn-doped II-VI nanocrystals, [ 1,2,7,17 ] 
the PL emission from the Mn dopants in PbS is either not observed 
or else is much weaker than the QD PL emission ( Figure  3 a,b): the 
weak Mn-related PL band is centered at ≈1.9 eV at room tempera-












 Figure 3.  a) Normalized PL spectra of Mn-doped PbS nanocrystals with  x from 0 to 18% ( T = 
295 K). b) PL spectrum for  x = 7% showing the Mn-dopant PL emission at 1.9 eV and the QD 
PL emission at 1.2 eV ( T = 295 K). c) Temperature dependence of the QD PL peak,  E QD , for 
 x = 0, 3, and 7%. 
 Figure 4.  Dependence of the QD PL peak energy,  E QD , on  x ( T = 295 K). 
The continuous line represents the calculated dependence of  E QD on  x 
according to the model described in the text. The inset shows the Mn 
content as estimated from EDX (Mn EDX , stars) and from the calculated 
and measured values of  E QD (Mn PL , dots). To account for different values 
of  E QD at  x = 0%, in the calculation of  E QD, we have assumed QD radii in 
the range  R = 2.5–2.6 nm. of the nanocrystals (see Figure  3 b). Also, while the Mn-related PL 
band does not change with  x , the QD PL emission tends to blue-
shift with increasing  x : for PbS QDs with no Mn, the PL band is 
centered at  E QD = 1.08 eV ( λ = 1150 nm) at  T = 295 K; increasing 
Mn results in a monotonic energy blue-shift of the PL emission up 
to a value of  E QD = 1.40 eV ( λ = 885 nm) at  x = 18% (see Figure  3 a). 
Correspondingly, the PL intensity decreases by less than a factor of 
10 going from  x = 0 to 18%, thus indicating a low level of thermal 
escape of carriers from the dots and a low density of Mn-induced 
non-radiative recombination centers. 
 Since the TEM and AFM studies show that the average 
diameter and size distribution of the nanocrystals are not 
changed by the Mn incorporation, we attribute the blue-
shift of the QD PL emission to a change in the composi-
tion of the nanocrystals. According to Vegard’s law, the 
bandgap energy,  E g , of a (PbMn)S alloy with Mn fraction,  x , 
is given by EPbMnS
g
(x) = (1 − x)E PbSg + xEMnSg  , where EPbSg  = 
0.41 eV and EMnSg  = 3.10 eV are the bandgap energies at 
 T = 295 K for bulk PbS and MnS, respectively. [ 18,19 ] The 
widening of the bandgap by Mn doping induces a corre-
sponding increase of the exciton recombination energy,  E QD , 
which we estimate by using a simple spherical model, [ 20 ] i.e., 
EQD = [E 2g (x) + 2
2Eg(x)B 2m∗ −1 R−2]1/2  , m∗ = 0.09me where 
is an average effective mass and  R = 2.5 nm is the QD radius. 
As shown in  Figure  4 , the calculated value of  E QD increases with 
increasing  x and describes well the measured values of  E QD at 
small  x (<3%). We attribute the disagreement at larger  x to a par-
tial incorporation of Mn in the nanocrystal: the Mn concentra-
tion, Mn PL , derived from the measured and calculated depend-
ence of  E QD on  x , is consistent with that derived from the EDX 
studies (Mn EDX ), see inset of Figure  4 . Thus, this analysis indi-
cates an effective Mn content in the nanocrystals of up to 8%. © 2013 The Authors. Published by WILEY-VCH Verlag GmPart. Part. Syst. Charact. 2013, 30, 945–949 For alloyed (PbMn)S nanoparticles, we 
expect a decrease of the temperature coeffi -
cient α = ∂E /∂ T  , describing the temperature 
dependence of the PL peak energy. In fact, 
the value of α  is positive for bulk PbS (αPbS 
= + 0.52 meV K –1 ), [ 18 ] but negative for MnS 
( MnSα  = −2 meV K –1 ). [ 19 ] As it can be seen in 
Figure  3 c, for PbS QDs (no Mn), we observe 
an energy blue-shift of the PL band that is 
approximately linear for  T > 100 K. This is 
described by the coeffi cient αPbSQD = ∂EQD/∂ T  
= + 0.3 meV K –1 , similar to that reported 
before for PbS QDs of similar size. [ 21–23 ] For 
samples incorporating Mn ( x > 1%), the coef-
fi cient becomes signifi cantly smaller, e.g., 
"PbMnSQD = + 0.12 meV K 
–1 for  x = 7%. These 
observations do not depend on the laser exci-
tation power used in the PL studies, which 
was varied over a wide range (i.e.,  P = 1–10 2 
W cm − 2 ) in all experiments. 
 In summary, this study shows that the 
incorporation of Mn atoms in PbS nanocrys-
tals has three main effects: i) it imparts the 
nanoparticles with paramagnetic properties; 
ii) it induces a blue-shift of the nanocrystal 
PL emission and a weaker temperature 
dependence of the PL peak energy due to the formation of alloyed nanoparticles; iii) also, it provides a 
means of tuning the PL emission of the nanocrystals in the 
technologically important biological window between 1.2  μ m 
and 0.8  μ m, never reported before for paramagnetic nanopar-
ticles in an aqueous solution. Thus, these properties could offer 
possibilities for medical imaging applications. Since the future 
implementation of these nanoparticles for imaging of living 













 Figure 5.  MTT assay for the human-derived breast cancer cell line MDA-
468 exposed to Mn-doped PbS nanocrystals with  x = 1% and 5% for 72 h. 
Error bars represent the standard deviation of the absorbance measured 
in eight wells. Inset: photograph of MDA-MB-468 cells. toxicity, [ 24–26 ] we now present preliminary cytotoxicity studies in 
human cells. 
 We performed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) assays on MRC-5 fetal lung fi broblast 
cells, which represent a normal phenotype, and on human-
derived breast cancer MDA-MB-468 (ER-) and colorectal cancer 
HCT-116 cell lines. We assessed the cell viability after 72 h 
exposure of cells to (PbMn)S nanoparticles at concentration 
ranging from 0.001 mg mL −1 to 10 mg mL −1 , and different Mn 
content.  Figure  5 presents a typical cytotoxicity profi le observed 
for MDA-MB-468 exposed to the Mn-doped PbS nanoparticles 
with  x = 1% and 5%. For both cancerous cell-lines, we observe 
a sharp decrease in cell viability with 50% growth inhibition 
(GI 50 ) values of ≈0.2 mg mL −1 . The normal cell line (MRC-5) 
is more resilient with a GI 50 value of 1 mg mL −1 . We note that 
the cell viability is not affected by the Mn content: the meas-
ured GI 50 values are comparable to those for PbS QDs where 
apoptotic cell death is caused by the Pb 2+ -induced increase in 
the reactive oxygen species (ROS). [ 24 ] Finally, the exposure of all 
cells to the nanoparticles at concentrations up to 0.2 mg mL −1 
does not induce any adverse effect, thus providing guidelines 
on safe doses for further toxicology studies in living organisms. 
 In conclusion, we have shown that Mn atoms can be incor-
porated in colloidal PbS nanocrystals in an aqueous solution. 
These nanoparticles are paramagnetic and their EPR spectra 
reveal features characteristic of the hyperfi ne interaction of the 
 d -electrons with the nuclear Mn spins. The blue-shift of QD PL 
emission with increasing Mn and the corresponding decrease 
of the PL energy shift with temperature indicate that alloyed 
(PbMn)S QDs are formed. The Mn atoms do not quench the 
NIR luminescence of the PbS QDs and imprint them with 
paramagnetic and optical properties tunable by the Mn content. 
This dual functionality and our preliminary results on cytotox-
icity in human-derived cell lines should stimulate further toxi-
cology studies and future exploitation of these nanoparticles in 
medical imaging. 948 wileyonlinelibrary.com © 2013 The Authors. Published by WILEY-VCH Verla Experimental Section 
 Morphological Characterization : For the transmission electron 
microscopy (TEM) study, the nanoparticles were deposited on a lacey-
carbon coated Cu grid or a graphene-coated grid, and TEM images were 
recorded on the JEOL1200EX and JEOL2100F microscopes operating at 
120 kV. EDX spectra and maps were recorded with an Oxford Instrument 
ultrathin-window EDX detector. The energy-fi ltered TEM images were 
obtained using a Gatan Tridiem imaging fi lter. Prior to these experiments, 
solutions were extensively dialyzed against de-ionized water to remove 
excess salts. For the AFM studies, the nanoparticles were dip-coated 
onto Si substrates. 
 Optical and Magnetic Studies : Room temperature ( T = 295 K) EPR 
measurements were recorded on a commercial Bruker E580 spectrometer. 
The measurements were carried out at K-band (23.9 GHz), with the 
microwave fi eld  B I perpendicular to the external magnetic fi eld  B 
(perpendicular mode), modulation amplitude of 0.5 mT and modulation 
frequency of 50 KHz. Magnetization measurements were carried out with 
a Quantum Design MPMS-XL5 superconducting quantum interference 
device (SQUID) magnetometer on pellet samples wrapped into Tefl on 
tape, which has negligible diamagnetic contribution. These measurements 
were performed with magnetic fi elds  B up to 5T. For PL experiments, the 
optical excitation was provided by the 514.5 nm line of an Ar + laser. The 
luminescence was dispersed by a 1/2 m monochromator and detected by 
a cooled (InGa)As photodiode or charge-coupled device (CCD) camera. 
As the QDs absorb over an extended wavelength range, their PL can be 
excited using different laser wavelengths up to the NIR wavelength range. 
 In Vitro Cytotoxicity Study : To probe the cytotoxicity of (PbMn)S, we 
performed MTT assays on MRC-5 fetal lung fi broblast cells, which 
represent a normal phenotype, and on human-derived breast cancer 
MDA-MB-468 (ER-) and colorectal cancer (HCT-116) cell lines. Cells were 
seeded into 96-well microtiter plates at a density of 5 × 10 3 per well and 
allowed 24 h to adhere. We assessed the cell viability after 72 h exposure 
to (PbMn)S with concentration in the range 0.001 mg mL −1 to 10 mg mL −1 
and Mn content of 1%, 5%, and 8%. Serial dilutions of (PbMn)S were 
prepared in RPMI nutrient medium supplemented with 10% fetal bovine 
serum. Control wells received vehicle alone. Experimental plates were 
incubated at 37 °C for a further 72 h. Exposure times and seeding 
concentrations were chosen to maintain confl uent monolayer of cells in 
the control well. Following exposure to the nanoparticles, MTT was added 
to each well at fi nal concentration 400  μ g mL −1 and plates incubated at 
37 °C for 2 h to allow reduction of MTT by viable cell dehydrogenases 
to insoluble dark purple formazan crystals. Well supernatants were 
aspirated and cellular formazan solubilized by addition of DMSO (150  μ L 
per well). Absorbance was read at  λ = 550 nm using an Anthos Labtec 
systems plate reader. The measured intensity is proportional to metabolic 
activity, which correlates to cellular viability. 
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 Supporting Information is available from Wiley Online Library or from 
the author. 
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